Made on
Tilda
: The 2026 budget is pushing firms away from low-margin generics toward higher-value innovation .
: One of the most efficient manufacturers with a high ESG score of 86, making it attractive for sustainability-focused institutional investors. Investment Considerations for 2026 which pharma stock to buy
Your (e.g., conservative large-caps or high-risk R&D specialists). : The 2026 budget is pushing firms away
: Companies like Roche and Amgen are leading the way by investing hundreds of millions into AI-driven drug discovery. If you'd like to refine your investment strategy , tell me: tell me: Your preferred (e.g.
Your preferred (e.g., short-term momentum or 5+ year growth).